AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. AAPG
  4. [6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)

[6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source:

Stock AAPG logo
Ascentage Pharma Group International

NASDAQ:AAPG

AAPG Rankings

#1480 Ranked by Market Cap
N/A Ranked by Dividends

AAPG Latest News

Aug 17, 2025
Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
Aug 7, 2025
Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025
Aug 1, 2025
Ascentage Pharma to Participate in Evercore China Biotech Summit
Jul 23, 2025
Ascentage Pharma to Participate in BTIG Virtual Biotechnology Conference 2025
Jul 17, 2025
Ascentage Pharma Announces Closing of Placement Shares in Top-Up Placement

AAPG Latest SEC Filings

Aug 18, 2025
[6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)
Aug 8, 2025
[6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)
Aug 7, 2025
[6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)
Jul 31, 2025
[6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)
Jul 25, 2025
[6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)

AAPG Stock Data

4.18B
92.96M
0.09%
0.01%
Biotechnology
Healthcare
China
Suzhou